Skip to main content
Reza Mehrazin, MD, Urology, New York, NY, The Mount Sinai Hospital

RezaMehrazinMD

Urology New York, NY

Minimally Invasive Surgery, Surgical Oncology

Urologic Oncology & Robotic Surgery

Overview of Dr. Mehrazin

Dr. Mehrazin’s clinical expertise is in robotic surgery, laparoscopic, and open surgical techniques for the treatment of various urologic cancers, which allows him to tailor a specific treatment plan based on individual patient need and preferences. He is one of the few urologists in the region who has extensive training and certified in performing minimally invasive organ preserving and reconstructive techniques to preserve function and quality of life for patients with kidney cancer and bladder cancer. He performs both robotic (using da Vinci® technology) and open cystectomies with continent urinary diversion (new bladder), nephron-sparing (kidney preserving) partial nephrectomy, nerve-sparing prostatectomy, partial or total adrenalectomy, retroperitoneal lymph node dissection for testicular cancer, and endoscopic nephron-sparing management of patients with upper tract urothelial carcinomas. He also has a special clinical interest in the management of patients with metastatic and advanced kidney cancer with tumors extending into the surrounding organs or major vessels, as well as salvage bladder surgeries following radiation therapy.

Education & Training

  • Temple University Hospital
    Temple University HospitalFellowship, Minimally Invasive Urologic Surgery, 2012 - 2014
  • University of Tennessee
    University of TennesseeResidency, Urology, 2008 - 2012
  • University of Tennessee
    University of TennesseeInternship, Transitional Year, 2007 - 2008
  • Medical University of the Americas
    Medical University of the AmericasClass of 2006

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2014 - 2025
  • PA State Medical License
    PA State Medical License 2011 - 2014
  • American Board of Urology Urology
  • Society of Urologic OncologySociety of Urologic Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Lymphopenia as an independent predictor of worse survival in papillary renal cell carcinoma.  
    Reza Mehrazin, Robert G. Uzzo, Alexander Kutikov, Jeffrey J. Tomaszewski, Serge Ginzburg, Karen J. Ruth, Essel Al-Saleem, David Y. T. Chen, Rosalia Viterbo, Richard E...., J Clin Oncol 32, 2014 (suppl 4; abstr 397)

Press Mentions

  • Novel Chemotherapy Delivery System May Fill Key Gap in Bladder Cancer Treatment
    Novel Chemotherapy Delivery System May Fill Key Gap in Bladder Cancer TreatmentMay 3rd, 2023
  • Minimally Invasive Partial Nephrectomy Does Not Worsen Cancer Outcomes
    Minimally Invasive Partial Nephrectomy Does Not Worsen Cancer OutcomesFebruary 25th, 2022
  • Kidney Cancer Gets Too Little Attention
    Kidney Cancer Gets Too Little AttentionOctober 11th, 2015
  • Join now to see all

Professional Memberships

Hospital Affiliations